Novo Nordisk CEO Flags 10 Deaths That Might Be Related To Compounded Semaglutide
The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, which are manufactured by Novo Nordisk. Compounded versions of the drug are made by other companies in times of shortages. FDA adverse event reports aren’t verified and don’t mean the drugs have caused the harms documented.